Klasteride
Klasteride is a synthetic opioid analgesic developed by the German pharmaceutical company Boehringer Ingelheim. It was first approved for medical use in Germany in 2004 and later in other European countries. Klasteride is a mu-opioid receptor agonist, meaning it binds to the same receptors in the brain that natural opioids like morphine do, thereby producing analgesic effects.
The drug is available in various forms, including tablets, oral solutions, and injectable suspensions. It is
One of the key advantages of klasteride is its rapid onset of action, usually within 15 to
Klasteride is not approved for use in the United States, but it is available in several European